CINXE.COM
Baxter Supported Nine New Abstract Presentations at the 55th ERA-EDTA Congress that Further Demonstrate Value of HDX Therapy Enabled by THERANOVA | Baxter
<!DOCTYPE html> <html lang="es" dir="ltr" prefix="og: https://ogp.me/ns#" class="no-js"> <head> <meta charset="utf-8" /> <link rel="canonical" href="https://www.baxter.mx/es/es/noticias-baxter/baxter-supported-nine-new-abstract-presentations-55th-era-edta-congress-further" /> <meta property="og:site_name" content="Baxter" /> <meta property="og:type" content="article" /> <meta property="og:url" content="https://www.baxter.mx/es/es/noticias-baxter/baxter-supported-nine-new-abstract-presentations-55th-era-edta-congress-further" /> <meta property="og:title" content="Baxter Supported Nine New Abstract Presentations at the 55th ERA-EDTA Congress that Further Demonstrate Value of HDX Therapy Enabled by THERANOVA" /> <meta property="article:section" content="Comunicado de prensa" /> <meta property="article:published_time" content="2018-05-30T12:00:00+0000" /> <meta name="twitter:card" content="summary_large_image" /> <meta name="Generator" content="Drupal 10 (https://www.drupal.org)" /> <meta name="MobileOptimized" content="width" /> <meta name="HandheldFriendly" content="true" /> <meta name="viewport" content="width=device-width, initial-scale=1.0" /> <link rel="alternate" hreflang="es" href="https://www.baxter.mx/es/es/noticias-baxter/baxter-supported-nine-new-abstract-presentations-55th-era-edta-congress-further" /> <link rel="alternate" hreflang="en" href="https://www.baxter.mx/en/en/baxter-newsroom/baxter-supported-nine-new-abstract-presentations-55th-era-edta-congress-further" /> <link rel="icon" href="/core/misc/favicon.ico" type="image/vnd.microsoft.icon" /> <script src="/sites/g/files/ebysai1591/files/google_tag/mexico/google_tag.script.js?srmomw" defer></script> <title>Baxter Supported Nine New Abstract Presentations at the 55th ERA-EDTA Congress that Further Demonstrate Value of HDX Therapy Enabled by THERANOVA | Baxter</title> <link rel="preload" href="/profiles/custom/bax_base/themes/bax_base_theme/build/fonts/roboto/roboto-regular.woff2" as="font" type="font/woff2" crossorigin="anonymous"> <link rel="preload" href="/profiles/custom/bax_base/themes/bax_base_theme/build/fonts/geogrotesque/36876D_0_0.woff2" as="font" type="font/woff2" crossorigin="anonymous"> <link rel="preload" href="/profiles/custom/bax_base/themes/bax_base_theme/build/fonts/geogrotesque/367E70_0_0.woff2" as="font" type="font/woff2" crossorigin="anonymous"> <link rel="preload" href="/profiles/custom/bax_base/themes/bax_base_theme/build/fonts/geogrotesque/368766_0_0.woff2" as="font" type="font/woff2" crossorigin="anonymous"> <link rel="preload" href="/profiles/custom/bax_base/themes/bax_base_theme/build/fonts/icomoon/icomoon.woff2" as="font" type="font/woff2" crossorigin="anonymous"> <script> // If fonts are cached, skip FFO. if (sessionStorage.fontsLoaded === 'true') { document.documentElement.classList.add('fonts-loaded'); } else { var script = document.createElement('script'); script.src = "/profiles/custom/bax_base/themes/bax_base_theme/build/scripts/fontloader.built.js"; script.async = true; document.head.appendChild(script); } </script> <link rel="stylesheet" media="all" href="/sites/g/files/ebysai1591/files/css/css_SHSejPhzVJkminuiQPhZ0E1Zz3lHuOWKn6fyKc-C2iY.css?delta=0&language=es&theme=bax_commercial_theme&include=eJxljUEOwyAMBD8E4UnRUlygMgHZpiq_r3poI6W31cxIm2BgLJIQqeBZu6jTpUYtRCi5iNf-GbsVahQe6u-9G8lVZO4R7NUW1yP_WWs-fZ_cgCALRtGQZA7wdpJtHmNGrlooOTVYVau3X3iSNzACSJM" /> <link rel="stylesheet" media="all" href="/sites/g/files/ebysai1591/files/css/css_KUrjSAnd6RvSnq4bKavrhqTyYFR-sdRdtmvAMFgml3E.css?delta=1&language=es&theme=bax_commercial_theme&include=eJxljUEOwyAMBD8E4UnRUlygMgHZpiq_r3poI6W31cxIm2BgLJIQqeBZu6jTpUYtRCi5iNf-GbsVahQe6u-9G8lVZO4R7NUW1yP_WWs-fZ_cgCALRtGQZA7wdpJtHmNGrlooOTVYVau3X3iSNzACSJM" /> <link rel="shortcut icon" href="/profiles/custom/bax_base/themes/bax_base_theme/build/favicon.ico"> <link rel="apple-touch-icon" sizes="180x180" href="/profiles/custom/bax_base/themes/bax_base_theme/build/apple-touch-icon.png"> <link rel="icon" type="image/png" sizes="32x32" href="/profiles/custom/bax_base/themes/bax_base_theme/build/favicon-32x32.png"> <link rel="icon" type="image/png" sizes="16x16" href="/profiles/custom/bax_base/themes/bax_base_theme/build/favicon-16x16.png"> <link rel="manifest" href="/profiles/custom/bax_base/themes/bax_base_theme/build/site.webmanifest"> <link rel="mask-icon" href="/profiles/custom/bax_base/themes/bax_base_theme/build/safari-pinned-tab.svg" color="#154898"> <meta name="msapplication-TileColor" content="#154898"> <meta name="msapplication-config" content="/profiles/custom/bax_base/themes/bax_base_theme/build/browserconfig.xml"> <meta name="theme-color" content="#154898"> <link rel="dns-prefetch" href="//players.brightcove.com"> <link rel="dns-prefetch" href="//c.brightcove.com"> <link rel="dns-prefetch" href="//edge.api.brightcove.com"> <link rel="dns-prefetch" href="//f1.media.brightcove.com"> <link rel="dns-prefetch" href="//vjs.zencdn.net"> <link rel="dns-prefetch" href="//www.googletagmanager.com"> </head> <body class="path-node page-node-type-post-page"> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NXVKHPF" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas> <ul class="skip" data-module="SkipLink"> <li> <a href="#main-content"> Pasar al contenido principal </a> </li> </ul> <header class="global-header"> <div> <div class="announcement" id="announcement" data-module="AnnouncementBanner" data-rev-id="46" hidden> <div class="wrapper"> <span class="date"> <time datetime="2025-02-03T12:00:00Z">02/03/2025</time> </span> <p> Los negocios de atención renal y terapias agudas de Baxter son ahora una empresa independiente, Vantive. Para más información por favor visite </p> <a href="https://www.vantive.lat" class="arrow-link">https://www.vantive.lat</a> <div class="close-btn icon-close"> <span class="visually-hidden">Close</span></div> </div> </div> </div> <div class="wrapper--wide"> <nav aria-labelledby="block-bax-commercial-utility-menu-menu-label" id="block-bax-commercial-utility-menu" class="nav__utility"> <div class="visually-hidden" id="block-bax-commercial-utility-menu-menu-label">Utility Menu</div> <ul> <li> <a href="/es/noticias-baxter" data-drupal-link-system-path="node/1996">Noticias</a> </li> <li> <a href="https://investor.baxter.com">Inversores</a> </li> <li> <a href="/es/careers" data-drupal-link-system-path="node/3001">Carrera</a> </li> <li> <a href="/es/partners-suppliers" data-drupal-link-system-path="node/1731">Socios y proveedores</a> </li> <li> <a href="/es/contactanos" data-drupal-link-system-path="node/1881">Contáctenos</a> </li> <li> <a href="https://www.baxter.com/Location-Selector">Sitio Mexico</a> </li> </ul> </nav> <div class="footer__lower"> <a href="/es" title="Inicio" rel="home" class="logo center"> <svg xmlns="http://www.w3.org/2000/svg" version="1" viewBox="-.203 -.077 749 127"><path fill="#154898" fill-rule="evenodd" d="M442.803 20.213c13.998-2.363 29.496-1.557 44.05-3.216-.095 6.022-2.83 11.892-4.23 17.89l1.348.88 35.37-.238-3.92 14.927-36.65.58c-5.023 14.88-8.865 30.332-13.147 45.557.07 3.907 3.156 6.16 6.375 7.847 11.16 0 24.25 1.72 34.04-2.146l-4.627 17.02-60.897.485c-8.298-1.296-16.777-8.93-18.426-16.654l.347-10.97c7.115-23.76 13.497-48.015 20.37-71.963zM301.536 37.348c11.05 15.497 21.2 31.215 30.39 47.517-17.155 12.236-34.573 23.85-51.912 35.416l.038.9 28.54-.48 32.298-21.713c4.857 6.804 9.512 13.776 12.12 21.522l54.84-.573c-1.183-.3-2.143-1.702-3.103-2.39l-26.704-43.693 54.172-36.895-.05-.88-32.678 1.062c-8.14 10.027-20.53 15-30.778 22.4-4.496-7.338-10.673-13.958-11.78-22.584l-55.394.39zm354.315-2.253l.644 4.21-19.64 72.353-4.775 7.15h51.835l-1.087-5.79 12.712-48.902c.52-2.844 2.91-5.698 5.716-6.966 10.788.162 26.81-3.452 36.72 2.39l6.372-24.283c-16.218 2.525-38.136-7.336-47.482 9.775-1.55-2.81-.686-6.534-.902-9.912l-40.113-.025zM144.385 6L40 6.442l.174 8.134-26.8 94.527L6 122.603l111.555-.065c10.092.226 18.736-2.926 23.334-10.91 3.347-11.727 9.362-22.758 8.004-35.828-1.628-5.084-5.47-9.773-10.265-12.853 4.724-1.315 9.432-3.016 13.14-6.602 7.913-10 10.332-22.583 10.65-34.937-1.79-7.56-9.856-14.11-18.036-15.408zm-56.5 19.302l27.372.226c3.804 2.074 2.426 7.385 1.543 10.21-2.4 5.706-2.234 13.296-7.84 17.09l-31.39.136 10.315-27.662zM72.06 72.122l29.088-.12c4.028 1.707 3.01 7.186 1.912 10.22-3.686 6.6.554 16.764-7.305 20.44L64.1 102.62c1.35-10.1 5.316-20.38 7.958-30.498zm195.836-34.264l-91.567.298-6.463 15.433c22.074-3.18 45.925-1.06 68.017-1.64 1.922.878 2.91 2.788 3.135 4.72-.89 2.645-.64 6.185-3.85 7.653l-60.258 1.342-10.5 4.89c-8.555 8.814-10.42 20.154-11.156 31.973.514 6.88 5.377 13.182 11.684 16.787 14.04 4.166 33.698 2.12 50.3 1.64 3.812-.953 6.31-4.72 8.112-7.753 1.378 2.48 2.434 5.26 3.25 7.904l43.094.19-1.39-5.795 12.72-46.8c1.99-6.05 3.913-14.538-.398-19.945-2.91-5.43-8.993-8.88-14.728-10.897zm-34 42.93l-6.404 22.7-2.765 2.166-21.753.345c-9.365-5.13-.293-15.525.534-22.955l3.53-2.18 26.86-.076zm392.12-44.844l-82.648-.415c-6.243 1.15-11.86 4.764-15.7 10.1-5.717 17.752-11.08 35.696-14.296 54.433 1.46 8.653 8.406 17.158 17.94 19.143l90.737-.237 7.073-17.454-4.53 1.886-62.188.46-3.253-1.52c-4.996-5.747.943-11.658 1.583-17.522l74.84-1.19c2.047-11.87 10.326-23.652 4.24-36.46-2.558-5.083-8.277-9.75-13.8-11.226zm-52.87 15.32l20.055-.32c1.872.48 3.988 2.204 4.627 4.16-.146 4.21-.978 8.305-2.66 12.21l-29.486.49c2.564-5.526 1.65-13.09 7.463-16.54z"/></svg> </a> <nav aria-labelledby="block-bax-commercial-main-nav-menu-label" id="block-bax-commercial-main-nav" class="nav__primary" data-module="MegaNav"> <div class="visually-hidden" id="block-bax-commercial-main-nav-menu-label">Main Menu</div> <ul> <li> <a role="button" tabindex="0" aria-haspopup="true" aria-controls="d888da05-01f8-441c-bc27-4a3e98de8127" aria-expanded="false" data-menu="d888da05-01f8-441c-bc27-4a3e98de8127" class="arrow-link down-arrow">Público en general</a> </li> <li> <a role="button" tabindex="0" aria-haspopup="true" aria-controls="0dd4697f-6549-408e-990e-f6ea1d872253" aria-expanded="false" data-menu="0dd4697f-6549-408e-990e-f6ea1d872253" class="arrow-link down-arrow">Información Médica</a> </li> <li> <a role="button" tabindex="0" aria-haspopup="true" aria-controls="aa43e5ff-af25-496f-aa75-d2786cc95ee9" aria-expanded="false" data-menu="aa43e5ff-af25-496f-aa75-d2786cc95ee9" class="arrow-link down-arrow">Perspectivas</a> </li> <li> <a role="button" tabindex="0" aria-haspopup="true" aria-controls="37f3c650-b899-435c-80cd-9c26f5a81ed5" aria-expanded="false" data-menu="37f3c650-b899-435c-80cd-9c26f5a81ed5" class="arrow-link down-arrow">Quiénes somos</a> </li> </ul> </nav> <nav class="nav__product-search" data-module="SearchToggle"> <ul> <li> <a href="/es/nuestros-productos" data-menu="77f8904c-bc65-4fa1-b76c-41bb61783db4">Nuestros productos</a> </li> <li> <button type="button" class="search"> <span class="visually-hidden">Search</span> <span class="icon-search"></span> </button> </li> </ul> </nav> <button class="menu-toggle" aria-label="Menu" aria-expanded="false" aria-controls="mobileNav" aria-hidden="false"> <span class="menu-toggle-box"> <span class="menu-toggle-inner"></span> </span> </button> </div> </div> <div class="search-bar"> <div class="search-bar__inner wrapper--wide"> <form action="/es/search" method="get" id="global-search-form" accept-charset="UTF-8"> <label for="search_api_fulltext" class="visually-hidden">Search</label> <input id="search_api_fulltext" type="text" class="search-bar__input" name="search_api_fulltext" placeholder="Search..."> </form> </div> </div> <div id="mega-nav" class="mega-nav"> <div class="mega-nav--inner wrapper--wide" id="nav0dd4697f-6549-408e-990e-f6ea1d872253"> <div class="feature"> <h2 class="mega-nav__heading">Información Médica</h2> <p> Estamos comprometidos con ayudarlo a superar los nuevos desafíos y oportunidades en la atención al paciente. </p> <a href="/es/Informacion-medica" class="button arrow-link">Información Médica</a> </div> <div class="links"> <ul> <li> <a href="/es/healthcare-professionals/critical-care" class="arrow-link"> Atención en cuidados críticos </a> <p> Proporcionamos terapias y tecnologías innovadoras para ayudarlo a tratar a los pacientes con enfermedades potencialmente mortales en la UCI. </p> </li> <li> <a href="/es/healthcare-professionals/hospital-care" class="arrow-link"> Atención hospitalaria </a> <p> De la farmacia a la cama del paciente, usted y sus prestadores de la salud cuentan con nuestro apoyo con medicamentos intravenosos y tecnologías de infusión diseñadas pensando en la seguridad. </p> </li> <li> <a href="/es/healthcare-professionals/nutritional-care" class="arrow-link"> Atención nutricional </a> <p> Cuidados intensivos y atención nutricional para pacientes que no pueden obtener los nutrientes adecuados por vía oral o entérica. </p> </li> <li> <a href="/es/healthcare-professionals/renal-care" class="arrow-link"> Atención renal </a> <p> Innovación pionera en hemodiálisis y diálisis peritoneal para ayudar a mejorar los resultados para sus pacientes. </p> </li> <li> <a href="/es/informacion-medica/atencion-quirurgica" class="arrow-link"> Atención quirúrgica </a> <p> Ofrecer productos quirúrgicos innovadores que le ayudan a trabajar con seguridad, precisión y velocidad. </p> </li> <li> <a href="/es/nuestros-productos" class="arrow-link"> Nuestros productos </a> <p> Nuestro portafolio de productos de atención crítica, nutricional, renal, hospitalaria y quirúrgica contribuye al progreso de la atención médica en todo el mundo. </p> </li> </ul> </div> </div> <div class="mega-nav--inner wrapper--wide" id="navaa43e5ff-af25-496f-aa75-d2786cc95ee9"> <div class="feature"> <h2 class="mega-nav__heading">Perspectivas</h2> <p> Hace más de 85 años que trabajamos en la intersección entre salvar y sostener vidas. </p> <a href="/es/perspectivas" class="button arrow-link">Perspectivas</a> </div> <div class="links"> <ul> <li> <a href="/es/perspectives/healthcare-insights" class="arrow-link"> Perspectivas sobre la salud </a> <p> Trabajamos junto con expertos del sector para explorar de qué forma la ciencia y la innovación contribuyen al progreso de la atención médica. </p> </li> <li> <a href="/es/perspectivas/compromiso-con-la-comunidad" class="arrow-link"> Compromiso con la comunidad </a> <p> Mejoramos las comunidades en donde vivimos y trabajamos. </p> </li> </ul> </div> </div> <div class="mega-nav--inner wrapper--wide" id="nav37f3c650-b899-435c-80cd-9c26f5a81ed5"> <div class="feature"> <h2 class="mega-nav__heading">Quiénes somos</h2> <p> Nuestra trayectoria de más de 85 años nos otorga una perspectiva clara sobre las necesidades de los pacientes y los cuidadores. Somos líderes hoy porque aprovechamos esa perspectiva para proporcionar nuevas </p> <a href="/es/quienes-somos" class="button arrow-link">Quiénes somos</a> </div> <div class="links"> <ul> <li> <a href="/es/quienes-somos/baxter-mexico" class="arrow-link"> Baxter México </a> <p> En el mes de octubre de 1948, hace 71 años, llegamos a México con la misión de salvar y mantener vidas. Desde entonces y hasta hoy este objetivo se ha mantenido intacto y enmarca todo el quehacer de nuestra corporación. </p> </li> <li> <a href="/es/our-story/our-governance" class="arrow-link"> Nuestra gobernanza </a> <p> Estamos orgullosos de nuestro firme compromiso de mantener los más altos estándares de gobernanza corporativa. </p> </li> <li> <a href="/es/our-story/fueling-collaborative-innovation" class="arrow-link"> Impulsamos la innovación colaborativa </a> <p> Fomentar una cultura de innovación es esencial para cumplir con nuestra misión de salvar y sostener vidas. Trabajamos codo a codo con la comunidad de la atención médica para encontrar continuamente formas nuevas y más inteligentes </p> </li> <li> <a href="/es/our-story/corporate-responsibility" class="arrow-link"> Responsabilidad corporativa </a> <p> Nos comprometemos a hacer negocios de la manera correcta, garantizando la defensa de los intereses de nuestros empleados, nuestras comunidades, nuestros clientes y pacientes, así como el cuidado del medioambiente en todo lo que hacemos. </p> </li> <li> <a href="/es/carrera/diversidad-e-inclusion" class="arrow-link"> Diversidad e inclusión </a> <p> Queremos atraer, motivar y retener a una fuerza laboral inclusiva y diversa. </p> </li> <li> <a href="/es/quienes-somos/nuestra-historia" class="arrow-link"> Nuestra historia </a> <p> Hace más de 85 años que nos concentramos en salvar y sostener vidas y mejorar la atención al paciente. </p> </li> </ul> </div> </div> <div class="mega-nav--inner wrapper--wide" id="navd888da05-01f8-441c-bc27-4a3e98de8127"> <div class="feature"> <h2 class="mega-nav__heading">Público en general</h2> <p> Le ayudamos a llevar una vida saludable, llena de posibilidades. </p> <a href="/es/publico-en-general" class="button arrow-link">Público en general</a> </div> <div class="links"> <ul> <li> <a href="" class="arrow-link"></a> <p></p> </li> </ul> </div> </div> </div> <div class="mobile-nav" data-module="MobileNav" id="mobileNav"> <div class="mobile-nav__content"> <div class="search-bar"> <div class="search-bar__inner wrapper--wide"> <form action="/es/search" method="get" id="global-search-form--2" accept-charset="UTF-8"> <label for="search_api_fulltext" class="visually-hidden">Search</label> <input id="search_api_fulltext" type="text" class="search-bar__input" name="search_api_fulltext" placeholder="Search..."> </form> </div> </div> <ul class="mobile-nav__items"> <li class="mobile-nav__item"> <a href="/es/publico-en-general" data-drupal-link-system-path="node/2686">Público en general</a> </li> <li class="mobile-nav__item has-children"> <a href="/es/Informacion-medica" data-drupal-link-system-path="node/1441">Información Médica</a> <button type="button" class="mobile-nav__subitems-trigger" aria-expanded="false" aria-controls="mobile-subnav-meganav-información-médica" aria-label="Open sub menu"> <span class="subnav__toggle arrow-link down-arrow"></span> </button> <ul class="mobile-nav__items mobile-nav__subitems" aria-hidden="true" id="mobile-subnav-meganav-información-médica"> <li class="mobile-nav__item"> <a href="/es/healthcare-professionals/hospital-care" data-drupal-link-system-path="node/2741">Atención hospitalaria</a> </li> <li class="mobile-nav__item"> <a href="/es/healthcare-professionals/nutritional-care" data-drupal-link-system-path="node/21">Atención nutricional</a> </li> <li class="mobile-nav__item"> <a href="/es/healthcare-professionals/renal-care" data-drupal-link-system-path="node/26">Atención renal</a> </li> <li class="mobile-nav__item"> <a href="/es/healthcare-professionals/critical-care" data-drupal-link-system-path="node/16">Atención crítica</a> </li> <li class="mobile-nav__item"> <a href="/es/informacion-medica/atencion-quirurgica" data-drupal-link-system-path="node/31">Atención quirúrgica</a> </li> <li class="mobile-nav__item"> <a href="/es/informacion-medica/contactenos-profesionales-de-la-salud" data-drupal-link-system-path="node/3311">Contáctenos - Profesionales de la salud</a> </li> </ul> </li> <li class="mobile-nav__item has-children"> <a href="/es/perspectivas" data-drupal-link-system-path="node/1711">Perspectivas</a> <button type="button" class="mobile-nav__subitems-trigger" aria-expanded="false" aria-controls="mobile-subnav-meganav-perspectivas" aria-label="Open sub menu"> <span class="subnav__toggle arrow-link down-arrow"></span> </button> <ul class="mobile-nav__items mobile-nav__subitems" aria-hidden="true" id="mobile-subnav-meganav-perspectivas"> <li class="mobile-nav__item"> <a href="/es/perspectives/healthcare-insights" data-drupal-link-system-path="node/1901">Perspectivas sobre la salud</a> </li> <li class="mobile-nav__item"> <a href="/es/perspectivas/compromiso-con-la-comunidad" data-drupal-link-system-path="node/1906">Compromiso con la comunidad</a> </li> </ul> </li> <li class="mobile-nav__item has-children"> <a href="/es/quienes-somos" data-drupal-link-system-path="node/1796">Quiénes somos</a> <button type="button" class="mobile-nav__subitems-trigger" aria-expanded="false" aria-controls="mobile-subnav-meganav-quiénes-somos" aria-label="Open sub menu"> <span class="subnav__toggle arrow-link down-arrow"></span> </button> <ul class="mobile-nav__items mobile-nav__subitems" aria-hidden="true" id="mobile-subnav-meganav-quiénes-somos"> <li class="mobile-nav__item"> <a href="/es/our-story/corporate-responsibility" data-drupal-link-system-path="node/1861">Responsabilidad Corporativa</a> </li> <li class="mobile-nav__item"> <a href="/es/our-story/fueling-collaborative-innovation" data-drupal-link-system-path="node/1876">Impulsamos la innovación colaborativa</a> </li> <li class="mobile-nav__item"> <a href="/es/quienes-somos/baxter-mexico" data-drupal-link-system-path="node/3296">Baxter in Mexico</a> </li> <li class="mobile-nav__item"> <a href="/es/quienes-somos/responsabilidad-corporativa" data-drupal-link-system-path="node/4036">Corporate Responsibility</a> </li> <li class="mobile-nav__item"> <a href="/es/quienes-somos/nuestra-historia" data-drupal-link-system-path="node/1716">Nuestra historia</a> </li> </ul> </li> </ul> <ul class="mobile-nav__items utility"> <li class="mobile-nav__item"> <a href="/es/noticias-baxter" class="arrow-link" data-drupal-link-system-path="node/1996">Noticias</a> </li> <li class="mobile-nav__item"> <a href="https://investor.baxter.com" class="arrow-link">Inversores</a> </li> <li class="mobile-nav__item"> <a href="/es/careers" class="arrow-link" data-drupal-link-system-path="node/3001">Carrera</a> </li> <li class="mobile-nav__item"> <a href="/es/partners-suppliers" class="arrow-link" data-drupal-link-system-path="node/1731">Socios y proveedores</a> </li> <li class="mobile-nav__item"> <a href="/es/contactanos" class="arrow-link" data-drupal-link-system-path="node/1881">Contáctenos</a> </li> <li class="mobile-nav__item"> <a href="https://www.baxter.com/Location-Selector" class="arrow-link">Sitio Mexico</a> </li> </ul> <ul class="mobile-nav__items utility"> <li class="mobile-nav__item"> <a href="/es/nuestros-productos" class="arrow-link" data-drupal-link-system-path="node/2816">Nuestros productos</a> </li> </ul> </div> </div> </header> <main class="main" id="main-content"> <header class="hero" style=""> <div class="hero-top wrapper--wide"> <div id="block-bax-commercial-breadcrumbs"> <nav role="navigation" aria-labelledby="system-breadcrumb" class="breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Ruta de navegación</h2> <ul> <li> <a href="/es">Inicio</a> </li> <li> <a href="/es/noticias-baxter">Noticias</a> </li> </ul> </nav> </div> </div> <div class="hero-content"> <div class="wrapper--wide"> <ul class="social-follow"> <li> <a href="https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.baxter.mx%2Fes%2Fes%2Fnoticias-baxter%2Fbaxter-supported-nine-new-abstract-presentations-55th-era-edta-congress-further" target="_blank" rel="noopener noreferrer" aria-label="Share on Linkedin"> <span class="icon-linkedin"></span> </a> </li> <li> <a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.baxter.mx%2Fes%2Fes%2Fnoticias-baxter%2Fbaxter-supported-nine-new-abstract-presentations-55th-era-edta-congress-further" target="_blank" rel="noopener noreferrer" aria-label="Share on Twitter"> <span class="icon-twitter"></span> </a> </li> <li> <a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.baxter.mx%2Fes%2Fes%2Fnoticias-baxter%2Fbaxter-supported-nine-new-abstract-presentations-55th-era-edta-congress-further" target="_blank" rel="noopener noreferrer" aria-label="Share on Facebook"> <span class="icon-facebook"></span> </a> </li> <li> <a href="/cdn-cgi/l/email-protection#132c677c2e35727e6328717c776a2e7b676763603620523621553621556464643d71726b6776613d7e6b362155766036215576603621557d7c677a707a72603e71726b67766136215571726b6776613e606663637c616776773e7d7a7d763e7d76643e72716067617270673e63617660767d6772677a7c7d603e2626677b3e7661723e767767723e707c7d74617660603e756661677b7661" target="_blank" rel="noopener noreferrer" aria-label="Share via Email"> <span class="icon-email"></span> </a> </li> </ul> <div class="hero-text"> <h1 class="hero-heading"> <span>Baxter Supported Nine New Abstract Presentations at the 55th ERA-EDTA Congress that Further Demonstrate Value of HDX Therapy Enabled by THERANOVA</span> </h1> </div> </div> </div> </header> <div class="wrapper--wide"> <div> <div data-drupal-messages-fallback class="hidden"></div> </div> <div> <div id="block-bax-commercial-content"> <div class="bookmark"> <div class="bookmark--text"> Comunicado de prensa </div> </div> <div class="key-takeaways"> <div class="wrapper"> <ul> <li><p><em>Data indicated HDx is superior to standard high-flux HD in the removal of middle and larger middle molecules</em></p></li> <li><p><em><em>Findings also indicated stable serum albumin levels using HDx therapy enabled by THERANOVA</em> </em></p></li> </ul> </div> </div> <section class="two-col--twothirds"> <div class="two-col--twothirds__container wrapper"> <div class="two-col--twothirds__right"> </div> <div class="two-col--twothirds__left"> <div class="wysiwyg"> <p class="page-tools"> <a href="/sites/g/files/ebysai1591/files/2018-05/Baxter%20HDx%20THERANOVA%20EDTA%20Release%20053018.pdf" target="_blank" aria-label="PDF"> <span class="icon icon-pdf"></span> PDF </a> </p> <p> <strong>COPHENHAGEN - <time datetime="2018-05-30T12:00:00Z">2018-05-30</time> </strong> </p> <p>Baxter International Inc. (NYSE: BAX), a global innovator in renal care, announced new data reinforcing that expanded hemodialysis (HDx) enabled by the THERANOVA dialyzer clears large middle molecules at a higher rate when compared to standard hemodialysis (HD), and equivalent or higher removal rates compared to high-volume hemodiafiltration (HDF). Two studies presented also found that albumin levels remained stable during HDx treatment. The findings were shared during scientific exchange at the 55<sup>th</sup> Congress of the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA), May 24-27. </p> <p>“HDx therapy enabled by THERANOVA was designed to filter a wider range of toxins from the blood than conventional HD filters, because we believe this is a critical step to transforming renal care and improving patient outcomes,” said Laura Angelini, general manager of Baxter’s Renal Care business. “We are committed to fully exploring and supporting robust scientific exchange about HDx therapy to understand its full potential for dialysis patients.”</p> <p>HDx enabled by THERANOVA is a unique type of HD therapy that targets the removal of large middle molecules<sup><a href="#_edn1">1</a></sup>, many of which are linked to the development of inflammation, cardiovascular disease, and other co-morbidities in dialysis patients<sup><a href="#_edn2">2</a></sup>. By extending the range of molecules that can be filtered from the blood, HDx results in a clearance profile that more closely mimics the natural kidney<sup><a href="#_edn3">3</a>,4</sup>. HDx is performed the same way as conventional hemodialysis (HD), does not require generation of replacement fluid, and works on standard equipment for operational efficiencies.</p> <p>One independent study specifically looked at the effects of HDx in comparison to high-flux HD in a conventional setting and found no loss of serum albumin or serum protein after using a new medium cut-off membrane (THERANOVA) in conventional HD compared to a high-flux dialyzer in hemodialfiltration: “Effects on Clinical and Dialytic Parameters with a New Medium Cut Off Membrane Dialyzer in Conventional Hemodialysis Compared to a High Flux Dialyzer in Online Hemodiafiltration” (Abstract SP468). </p> <p>In addition, no relevant differences were found in adequacy, anemia or parameters of bone mineral metabolism. These initial findings were a result of a controlled observational study with eight patients. For at least three months before the study, seven patients were on hemodiafiltration and one patient was on conventional HD, both with a high-flux dialyzer. </p> <p>Another independent study indicated HDx is superior to standard high-flux HD in the removal of middle and larger middle molecules, and it is not inferior to hemodiafiltration in the clearance of small and larger middle molecules: “Evaluation of the Efficacy of a Medium Cut Off Dialyzer and Comparison to other High Flux Dialyzers in Conventional Hemodialysis and Online Hemodiafiltration” (Abstract SaO041). </p> <p>These observations were made following a cross-over study of 18 prevalent HD patients in three single mid-week dialysis treatments during three consecutive weeks. Therapy was conducted the first week with hemodiafiltration, using a standard high-flux dialyzer; the second week treatment consisted of conventional HD with a standard high-flux dialyzer; and the third week conventional HD with the THERANOVA dialyzer. Reduction ratios of different sized molecules and albumin losses were collected for dialyzer use.</p> <p> Additional key data presentations on HDx enabled by THERANOVA included:</p> <ul> <li><em>Plasma Molecular Changes in Hemodialysis Patients with Polyarylethersulfone-Polyvinylpyrrolidone Membrane Dialyzer (THERANOVA 400 Baxter)</em>: Abstract FP444</li> <li><em>Expanded Hemodialysis vs Online Hemodiafiltration for Middle Sized Molecules Clearance</em>: Abstract FP453</li> <li><em>Comparison of High Flux Hemodialyzers with Medium Cut-Off Dialyzer on the Removal of Middle High Size Uremic Toxins</em>: Abstract FP458</li> <li><em>New Medium Cut-Off Membrane vs Online Hemodiafiltration in Clearance of Middle Molecules. Preliminary Results from Our Centre</em>: Abstract FP466</li> <li><em>A Mid-Term Report of HD Treatments with the New Dialyzers with Medium Cut-Off Membrane (MCO THERANOVA<sup>®</sup>)</em>: Abstract SP481</li> <li><em>Middle Cut Off (MCO) Dialyzers in Patients with Multiple Myeloma - Removal of Light Chains with HDx-Therapy:</em> Abstract SP486</li> <li><em>Mid-Term Evaluation of the New Medium Cut-Off Filter (THERANOVA) on Removal Efficiency and Quality of Life</em>: Abstract SP489</li> </ul> <p>A recent in vivo study published in <em>Clinical Nephrology</em> also had consistent findings, indicating no significant changes in albumin levels with equivalent removal of small and middle-sized molecules when comparing the THERANOVA 400 dialyzer with high-flux OL-HDF<sup><a href="#_edn5">5</a></sup>. </p> <p>HDx enabled by THERANOVA is currently available in Canada, Europe, select markets in Latin America, the Middle East and Far East, as well as Australia and New Zealand. THERANOVA is an investigational device in the United States, and is not approved for use in that market. </p> <p>In the fall of 2017, Baxter announced enrollment of the first patients in two new HDx therapy enabled by THERANOVA clinical trials, including a multi-center, prospective, randomized controlled clinical trial to support submission for marketing authorization from the U.S. Food and Drug Administration.</p> <p><strong><em>For prescription only.</em></strong><em> For safe and proper use of the devices mentioned herein, refer to the THERANOVA Instructions for Use. It cannot be used with </em><em>hemodiafiltration.</em><br> </p> <p><strong>About Baxter</strong></p> <p>Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit <a href="http://www.baxter.com/">www.baxter.com</a> and follow us on <a href="https://twitter.com/baxter_intl?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor">Twitter</a>, <a href="https://www.linkedin.com/company/baxter-healthcare/">LinkedIn</a> and <a href="https://www.facebook.com/BaxterInternationalInc/">Facebook</a>. </p> <p><em>This release includes forward-looking statements concerning THERANOVA, one of Baxter’s dialysis membranes, including expectations regarding its potential impact on patients and anticipated benefits associated with its use. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply, or patient safety issues; changes in law and regulations; and other risks identified in Baxter's most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.</em></p> <p> Baxter and THERANOVA are registered trademarks of Baxter International Inc.</p> <p> </p> <hr> <p><sup><a href="///C:/Users/careyhj/Desktop/Baxter%20HDx%20THERANOVA%20EDTA%20Release%20053018.doc#_ednref1">1</a></sup> Ronco C, et al. <em>The rise of Expanded Hemodialysis. </em>Blood Purif 2017; 44:1—VIII.</p> <p><sup>2</sup> Hutchison CA, et al. <em>The Rationale for Expanded Hemodialysis Therapy (HDx). </em>Contrib Nephrol 2017; 191:142-52. </p> <p><sup><a href="///C:/Users/careyhj/Desktop/Baxter%20HDx%20THERANOVA%20EDTA%20Release%20053018.doc#_ednref3">3</a></sup> Boschetti-de-Fierro A, et al. MCO membranes: Enhanced Selectivity in High-Flux Class. Scientific Reports (2015); 5: 18448.</p> <p><sup><a href="///C:/Users/careyhj/Desktop/Baxter%20HDx%20THERANOVA%20EDTA%20Release%20053018.doc#_ednref4">4</a></sup> Kirsch AH, et al. Performance of hemodialysis with novel medium cut-off dialyzers. Nephrol Dial Transplant. 2017;32:165-172.</p> <p><sup><a href="///C:/Users/careyhj/Desktop/Baxter%20HDx%20THERANOVA%20EDTA%20Release%20053018.doc#_ednref5">5</a></sup> Belmouaz M, et al. <em>Comparison of hemodialysis with medium cut-off dialyzer and on-line hemodiafiltration on the removal of small and middle size molecules. </em>Clinical Nephro 2018; 89 (1): 50-56.</p> </div> </div> </div> </section> </div> </div> </div> </main> <div> <div id="block-bax-commercial-default-footer"> <footer class="footer"> <div class="wrapper"> <div class="row footer--menu"> <div class="footer__links "> <a href="/es/publico-en-general"><h2 class="footer__links-heading">Público en General</h2></a> <ul> </ul> </div> <div class="footer__links "> <a href="/es/Informacion-medica"><h2 class="footer__links-heading">Información Médica</h2></a> <ul> <li> <a href="/es/healthcare-professionals/critical-care">Atención crítica</a></li> <li> <a href="/es/healthcare-professionals/hospital-care">Atención hospitalaria</a></li> <li> <a href="/es/healthcare-professionals/nutritional-care">Atención nutricional</a></li> <li> <a href="/es/healthcare-professionals/renal-care">Atención renal</a></li> <li> <a href="/es/informacion-medica/atencion-quirurgica">Atención quirúrgica</a></li> <li> <a href="/es/nuestros-productos">Nuestros productos</a></li> <li> <a href="https://baxter.benchmarkdigital.com/baxter/ehs/msds/index.cfm?siteID=2&pagetype=basic&scopeappconfigid=3&passCode=E9A1C7F528618141E3DE8FAA746E5508">Safety Data Sheets</a></li> </ul> </div> <div class="footer__links "> <a href="/es/perspectivas"><h2 class="footer__links-heading">Perspectivas</h2></a> <ul> <li> <a href="/es/perspectivas/perspectivas-del-director">Perspectivas del director ejecutivo</a></li> <li> <a href="/es/perspectives/healthcare-insights">Perspectivas sobre la salud</a></li> <li> <a href="/es/perspectivas/compromiso-con-la-comunidad">Compromiso con la comunidad</a></li> </ul> </div> <div class="footer__links "> <a href="/es/quienes-somos"><h2 class="footer__links-heading">Quiénes somos</h2></a> <ul> <li> <a href="https://www.baxter.com/our-story/our-leadership">Nuestro liderazgo</a></li> <li> <a href="/es/our-story/our-governance">Nuestra gobernanza</a></li> <li> <a href="/es/our-story/fueling-collaborative-innovation">Impulsamos la innovación colaborativa</a></li> <li> <a href="/es/our-story/corporate-responsibility">Responsabilidad corporativa</a></li> <li> <a href="/es/carrera/diversidad-e-inclusion">Diversidad e Inclusión</a></li> <li> <a href="/es/quienes-somos/nuestra-historia">Nuestra historia</a></li> <li> <a href="/es/policies-positions">Políticas y posturas</a></li> <li> <a href="/es/seguridad-de-los-productos">Seguridad de los productos</a></li> </ul> </div> <div class="footer__links "> </div> </div> <div class="row footer--social-selector"> <div class="footer__links"> </div> <div class="footer__links"> <ul class="social-follow"> <li> <a href="https://www.linkedin.com/showcase/baxter-m%C3%A9xico/" target="_blank" rel="noopener noreferrer" aria-label="linkedin"> <span class="icon-linkedin"></span> </a> </li> <li> <a href="https://www.facebook.com/BaxterInternationalInc/" target="_blank" rel="noopener noreferrer" aria-label="facebook"> <span class="icon-facebook"></span> </a> </li> <li> <a href="https://twitter.com/baxter_intl?WT.svl=www.baxter.com" target="_blank" rel="noopener noreferrer" aria-label="twitter"> <span class="icon-twitter"></span> </a> </li> <li> <a href="https://www.youtube.com/user/BaxterInternational?WT.svl=www.baxter.com" target="_blank" rel="noopener noreferrer" aria-label="youtube"> <span class="icon-youtube"></span> </a> </li> </ul> </div> </div> <div class="row footer--bottom"> <ul class="footer__utility"> <li> <a href="/es/policies-positions/global-privacy-policy">Politica Global de Privacidad</a></li> <li> <a href="/es/terminos-de-uso">Términos de Uso</a></li> <li> <a href="/es/site-map">Mapa del sitio</a></li> <li> <a href="/es/cookies">Cookies</a></li> </ul> <div class="footer__copyright"> <p>©Copyright 2025 Baxter. All rights reserved.</p> <p></p> </div> </div> </div> </footer> <!-- Global script includes --> </div> </div> <div style="display: none;"> <div> <div id="site-exit-prompt" class="modal " role="dialog" aria-labelledby="label-site-exit-prompt" data-module="SiteExitPrompt" style="display: none"> <div class="modal__content"> <h2 id="label-site-exit-prompt"> Usted está a punto de salir de la página Baxter México S.A de C.V </h2> <div class="modal__message"> <p>¿Desea continuar?</p> </div> <a href="#" class="button button--solid arrow-link" id=site-exit-stay> Rechazar </a> <a href="#" class="button button--solid arrow-link" id=site-exit-leave> Aceptar </a> </div> </div> </div> </div> </div> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>window.dataLayer = window.dataLayer || []; window.dataLayer.push({"drupalLanguage":"es","drupalCountry":"","siteName":"Baxter","entityCreated":"1527709753","entityLangcode":"es","entityStatus":"1","entityUid":"61","entityUuid":"4574aa2c-1916-46f8-b87a-5e883ed6f4e3","entityVid":"39426","entityName":"jhargrave","entityType":"node","entityBundle":"post_page","entityId":"2986","entityTitle":"Baxter Supported Nine New Abstract Presentations at the 55th ERA-EDTA Congress that Further Demonstrate Value of HDX Therapy Enabled by THERANOVA","entityTaxonomy":{"categories":{"1":"Press Release"},"specialty_areas":{"26":"Renal Care"}},"userUid":0});</script> <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"es\/","currentPath":"node\/2986","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"es"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"dataLayer":{"defaultLang":"es","languages":{"es":{"id":"es","name":"Spanish","direction":"ltr","weight":-10},"en":{"id":"en","name":"English","direction":"ltr","weight":-9}}},"statistics":{"data":{"nid":"2986"},"url":"\/core\/modules\/statistics\/statistics.php"},"ajaxTrustedUrl":{"\/es\/search":true},"user":{"uid":0,"permissionsHash":"9ad203cb0b1e73f01245365fdb6a229edc65d1de59bffe8de7a0e2cff1dd0741"}}</script> <script src="/sites/g/files/ebysai1591/files/js/js_FILdMmxGbBgcOOxBBaSajwZTFKSLJKRKPt75eWT6gKw.js?scope=footer&delta=0&language=es&theme=bax_commercial_theme&include=eJxljUEOwyAMBD8E4UnRUlygMgHZpiq_r3poI6W31cxIm2BgLJIQqeBZu6jTpUYtRCi5iNf-GbsVahQe6u-9G8lVZO4R7NUW1yP_WWs-fZ_cgCALRtGQZA7wdpJtHmNGrlooOTVYVau3X3iSNzACSJM"></script> </body> </html>